Search Within

Biostatistics Service

Formats
  1. Journal Article (4043)
  2. Meeting Abstract (2452)
  3. Research Letter (55)
  4. Conference Paper (37)
  5. Correspondence (28)
  6. Editorial (25)
  7. Review (23)
  8. Miscellaneous (16)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Epidemiology and Biostatistics (6697)
  2. Department of Medicine (3944)
  3. Solid Tumor Oncology Division (2622)
  4. Survivorship Research (2547)
  5. Surgery (2419)
  6. Population Sciences Research Program (2406)

More Groups

People
  1. Mithat Gonen (1037)
  2. Sean Devlin (616)
  3. Katherine Panageas (523)
  4. Sujata Patil (511)
  5. Sergio Giralt (480)
  6. Zhigang Zhang (432)

More People

Years
  1. 2025 (214)
  2. 2024 (399)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1077)
  2. Blood (468)
  3. Annals of Surgical Oncology (312)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (198)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1146)
  2. Elsevier Inc. (780)
  3. Springer (633)
  4. American Society of Hematology (526)
  5. American Association for Cancer Research (433)
  6. Nature Publishing Group (317)

More Publishers

Results (6697)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Systematic reviews of diagnostic accuracy studies require study by study examination: First for heterogeneity, and then for sources of heterogeneity
    Journal Article

    Begg, C. B.
    Journal of Clinical Epidemiology (2005)

    Fulltext@MSK | Save
  • Second-line chemotherapy for prostate cancer: Patient characteristics and survival
    Journal Article

    Beekman, K. W.; Fleming, M. T.; Scher, H. I.; Slovin, S. F.; Ishill, N. M.; Heller, G.; Kelly, W. K.
    Clinical Prostate Cancer (2005)

    Fulltext@MSK | Save
  • Androgen deprivation for minimal metastatic disease: Threshold for achieving undetectable prostate-specific antigen
    Journal Article

    Beekman, K.; Morris, M.; Slovin, S.; Heller, G.; Wilton, A.; Bianco, F.; Scardino, P. T.; Scher, H. I.
    Urology (2005)

    Fulltext@MSK | Save
  • Intravaginal brachytherapy alone for intermediate-risk endometrial cancer
    Journal Article

    Alektiar, K. M.; Venkatraman, E.; Chi, D. S.; Barakat, R. R.
    International Journal of Radiation Oncology, Biology, Physics (2005)

    Fulltext@MSK | Save
  • High dose chemoradiotherapy and ASCT can overcome the prognostic importance of bcl-2, bim, and p53 in relapsed/refractory Hodgkin's lymphoma
    Meeting Abstract

    Persky, Daniel; Teruya-Feldstein, Julie; Kewalramani, Tarun; Bonner, Pauline D; Iasonos, Alexia; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Zelenetz, Andrew D; Moskowitz, Craig H.
    Blood (2005)

    Fulltext@MSK | Save
  • The utility of consolidative upfront high dose chemoradiotherapy and ASCT in patients with mantle cell lymphoma (MCL)
    Meeting Abstract

    Persky, Daniel; Portlock, Carol S.; Lessac-Chenen, Simone; Iasonos, Alexia; Zelenetz, Andrew D; Kewalramani, Tarun; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Moskowitz, Craig H.
    Blood (2005)

    Fulltext@MSK | Save
  • Drug-induced cutaneous vasculitis in patients with non-Hodgkin's lymphoma receiving bortezomib: A possible surrogate marker of response
    Meeting Abstract

    Gerecitano, J.; Goy, A.; Macgregor-Cortelli, B.; Neylon, E.; Wright, J.; Esseltine, D.; Schenkein, D.; Gonen, M.; O'Connor, O. A.
    Blood (2005)

    Fulltext@MSK | Save
  • A statistical perspective on gene expression data analysis
    Book Section

    Satagopan, J. M.; Panageas, K. S.
    In D'Agostino, R. B. (Eds.) Tutorials in Biostatistics: Statistical Modelling of Complex Medical Data (2004)

    Fulltext@MSK | Save
  • Clinical significance of BRAF or NRAS mutations in metastatic melanoma
    Meeting Abstract

    Chang, D. Z.; Panageas, K. S.; Osman, I.; Polsky, D.; Chapman, P. B.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Langerhans cells modified by gene transfer of full length CMV pp65 are more potent inducers of cytolytic T lymphocytes in a CD4-dependent manner than either CMV p495 gene-modified or p495 peptide-pulsed Langerhans cells
    Meeting Abstract

    Yuan, J.; Latouche, J. B.; Hodges, J.; Heller, G.; Riviere, I.; Sadelain, M.; Young, J. W.
    Molecular Therapy (2004)

    Fulltext@MSK | Save